Key result
Intravenous benextramine irreversibly binds to peripheral alpha 1- and alpha 2-adrenoreceptors in rabbits, reducing binding site density and pressor responses, but fails to cross the blood-brain barrier.
Supports benextramine as a peripherally selective alpha-antagonist tool in rabbits; leaves open translation to human autonomic research.
The densities of [3H]-prazosin and [3H]-clonidine binding sites were determined in spleen and brain membrane preparations from rabbits treated 1 to 48 h previously with benextramine (5 mg/kg). In other rabbits pressor responses to phenylephrine and BHT 920 were examined 1 to 72 h after benextramine administration. After benextramine there was a reduction in the density of both [3H] prazosin and [3H] clonidine binding sites in spleen and a non-parallel shift in pressor dose response curves to selective alpha 1- and alpha 2-adrenoreceptor agonists. Recovery of in vivo responses and binding site densities were relatively slow. No reduction in the maximum density of either [3H] prazosin or [3H] clonidine binding sites in brain was found after intravenous administration of benextramine. It is concluded that after intravenous administration benextramine binds irreversibly to peripheral alpha 1- and alpha 2-adrenoreceptors in the rabbit but fails to cross the blood brain barrier in appreciable quantities and bind to central alpha-adrenoreceptors. Recovery of in vivo responses was more rapid than that previously observed after alpha-adrenoreceptor blockade with phenoxybenzamine. The longer time course of recovery after phenoxybenzamine may be a result of redistribution of this lipophilic drug from fat.
No takes yet. Share an insight, caveat, or question.
FURNACE et al. (1985) studied this question. Benextramine was evaluated on Density of [3H]-prazosin and [3H]-clonidine binding sites and pressor responses. Intravenous benextramine irreversibly binds to peripheral alpha 1- and alpha 2-adrenoreceptors in rabbits, reducing binding site density and pressor responses, but fails to cross the blood-brain barrier.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: